טוען...
Sequencing of anthracyclines and taxanes in neoadjuvant and adjuvant therapy for early breast cancer
BACKGROUND: Anthracyclines and taxanes are chemotherapeutic agents widely used in a sequential regimen in the adjuvant and neoadjuvant treatment of early breast cancer to reduce the risk of cancer recurrence. Standard practice is to administer anthracycline‐based chemotherapy followed by a taxane. A...
שמור ב:
| הוצא לאור ב: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
John Wiley & Sons, Ltd
2019
|
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6378927/ https://ncbi.nlm.nih.gov/pubmed/30776132 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012873.pub2 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|